Journal
EMERGING INFECTIOUS DISEASES
Volume 25, Issue 1, Pages 73-81Publisher
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2501.180807
Keywords
-
Categories
Funding
- National Institutes of Health [P01AI106705, 5R01NS083687]
- Charles S. Britton Fund
Ask authors/readers for more resources
Variably protease-sensitive prionopathy (VPSPr), a recently described human sporadic prion disease, features a protease-resistant, disease-related prion protein (resPrP(D)) displaying 5 fragments reminiscent of Gerstmann-Straussler-Scheinker disease. Experimental VPSPr transmission to human PrP-expressing transgenic mice, although replication of the VPSPr resPrP(D) profile succeeded, has been incomplete because of second passage failure. We bioassayed VPSPr in bank voles, which are susceptible to human prion strains. Transmission was complete; first-passage attack rates were 5%-35%, and second-passage rates reached 100% and survival times were 50% shorter. We observed 3 distinct phenotypes and resPrP(D) profiles; 2 imitated sporadic Creutzfeldt-Jakob disease resPrP(D), and 1 resembled Gerstmann-Straussler-Scheinker disease resPrPD. The first 2 phenotypes may be related to the presence of minor PrPD components in VPSPr. Full VPSPr transmission confirms permissiveness of bank voles to human prions and suggests that bank vole PrP may efficiently reveal an under-represented native strain but does not replicate the complex VPSPr PrPD profile.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available